Subscribe to Daily Review - your favourite M&A deals update.

Submit Deal

Argot Partners

Summary

Edit Data

Argot Partners is a strategic communications firm focused on the life sciences.

Market Context

Deals Overview

Edit Data

Total Deals50

Valued Deals38

Total Value£ 14.50 B

Avg. Deal Size£ 382 M

12 Feb 2025|United States|Biotechnology

Target: ABCURO

Bidder: REDMILE GROUP

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 161 M

Value

03 Dec 2024|United States|Pharmaceuticals

Target: UDENYCA

Bidder: INTAS PHARMACEUTICALS

6 Service Providers

2 Bidder | 4 Vendor

6 Dealmakers

2 Bidder | 4 Vendor

£ 440 M

Value

02 Dec 2024|Canada|Biotechnology

Target: KISOJI BIOTECHNOLOGY

Bidder: LUMIRA VENTURES

7 Service Providers

3 Target | 4 Bidder

15 Dealmakers

6 Target | 9 Bidder

£ 32 M

Value

29 Oct 2024|United States|Biotechnology

Target: CRESCENT BIOPHARMA INC

Bidder: GLYCOMIMETICS

12 Service Providers

8 Target | 4 Bidder

11 Dealmakers

4 Target | 7 Bidder

n/a

Value

09 May 2024|United States|Biotechnology

Target: BLUEJAY THERAPEUTICS

Bidder: ARKIN BIO VENTURES

3 Service Providers

2 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 145 M

Value

07 May 2024|United States|Biotechnology

Target: ZENAS BIOPHARMA

Bidder: FEDERATED HERMES

4 Service Providers

3 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 160 M

Value

29 Apr 2024|United States|Biotechnology

Target: DECIPHERA PHARMACEUTICALS

Bidder: ONO PHARMACEUTICAL

9 Service Providers

6 Target | 3 Bidder

59 Dealmakers

58 Target | 1 Bidder

£ 1.92 B

Value

03 Apr 2024|United States|Biotechnology

Target: ALTEROME THERAPEUTICS

Bidder: GOLDMAN SACHS ASSET MANAGEMENT

5 Service Providers

2 Target | 3 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 105 M

Value

16 Nov 2023|United States|Biotechnology

Target: HOMOLOGY MEDICINES INC

Bidder: Q32 BIO INC

9 Service Providers

4 Target | 5 Bidder

12 Dealmakers

4 Target | 8 Bidder

£ 92 M

Value

13 Nov 2023|United States|Biotechnology

Target: CARTESIAN THERAPEUTICS

Bidder: SELECTA BIOSCIENCES

6 Service Providers

2 Target | 4 Bidder

22 Dealmakers

1 Target | 21 Bidder

n/a

Value

31 Oct 2023|United States|Biotechnology

Target: LUNG THERAPEUTICS

Bidder: AILERON THERAPEUTICS

9 Service Providers

6 Target | 3 Bidder

8 Dealmakers

6 Target | 2 Bidder

n/a

Value

07 Sep 2023|United States|Biotechnology

Target: MARIANA ONCOLOGY

Bidder: DEEP TRACK CAPITAL

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 139 M

Value

See 50 deals that match your search results with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy